Survey study, 2020
Is the Japanese version of the DRSP a reliable tool for tracking PMS?
Yes. The Japanese DRSP is reliable and valid for tracking symptoms and diagnosing PMS in Japanese women, with very strong internal consistency.
What they did
Cross-sectional study. Researchers translated the DRSP following standard guidelines, then tested it on 119 women. Women completed the questionnaire twice, 2 weeks apart, with one set during their luteal phase (second half of cycle).
What they found
The Japanese DRSP had very high internal consistency (0.93). Scores during the luteal phase correlated highly with scores on depression, PMDD, and general health questionnaires.
What it means for you
The Japanese DRSP works well for Japanese women to track their daily premenstrual symptoms. This study developed and validated a tool but did not test a treatment.
119
women tested
0.93
internal consistency coefficient
About the study
- Original title
- Development of a Japanese Version of the Daily Record of Severity of Problems for Diagnosing Premenstrual Syndrome
- Authors
- Ikeda Y, Egawa M, Hiyoshi K et al.
- Journal
- Women's health reports (New Rochelle, N.Y.)
- Year
- 2020
- Study design
- Survey study
- Participants
- 119
- What was tested
- None. This developed and validated a symptom-tracking tool.
- Open access
- Yes
- Read the paper
- doi.org/10.1089/whr.2019.0004
Original abstract
Background: Premenstrual syndrome (PMS) causes physical and mental symptoms in women during the luteal phase of the menstruation cycle. To confirm the relationship between symptoms and the menstruation cycle, daily symptom records are essential for diagnosing PMS. The daily record of severity of problems (DRSP) is currently the most validated tool for tracking symptoms to confirm and scale the severity of PMS, but there has been no validated Japanese version of this instrument. We developed a Japanese version of the DRSP and assessed its psychometric properties. Methods: A Japanese version of the DRSP was developed following the translation guidelines of the latest Patient-Reported Outcomes Consortium. We conducted a computational psychometric study among 119 women, all of whom completed the Japanese version of the DRSP, the Center for Epidemiologic Studies Depression Scale (CES-D), the Premenstrual Dysphoric Disorder (PMDD) scale, and a Numerical Rating Scale (NRS) for general health status. Each was filled out twice, 2 weeks apart, so that one set was completed in the luteal phase. Results: The Japanese version of the DRSP was developed with translation and cultural adaptation. The internal consistency coefficient for the total score was 0.93. The DRSP in the luteal phase correlated highly with the CES-D, PMDD scale, and NRS for general health status. Conclusions: Our Japanese version of the DRSP, developed as a PMS/PMDD diagnostic tool, was shown to provide substantial validity and reliability to rate premenstrual symptoms for Japanese women.
Reproduced under CC-BY.
Topics
Related studies
Cohort study, 2026
What genetic factors are linked to premenstrual symptoms?
Systematic review, 2026
How often do mood disorders and PMS or PMDD occur together?
Systematic review, 2026
Does vitamin D supplementation help PMS symptoms?
Study, 2026
How do women with PMDD process emotions differently in their brains?
Systematic review, 2026
Why do some women experience mood changes linked to their menstrual cycle?
Systematic review, 2026
How much of PMDD treatment improvement comes from placebo effect?